Delivery Order SPE2DB25D3108-SPE2DB25FPDEP
Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a type of medication, with a ceiling value of $3,989.54 and a performance period ending on July 2, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,173.37 and covers the delivery of EXFORGE 10-320 MG TABLET 30S medication. The contract has a period of performance through July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,089.05 contract is for the provision of 4563783806 EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
- Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide EXFORGE 10-160 MG TABLET 30S with a potential value of $11,125.92. The contract has a performance period through January 31, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,419.41 by the Defense Logistics Agency (DLA) to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a total ceiling value of $2,465.80. The contract is a firm fixed-price, non-set-aside award with a completion date of June 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,743.68 firm fixed-price contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,594.58 and a period of performance through July 1, 2025. The contract is a firm-fixed-price delivery order, which means the vendor will deliver the specified quantity of the drug at a...
- This federal contract award, valued at $2,091.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...